Frequent donors were more likely to have different genetic changes in their blood stem cells, scientists found.

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...